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Summary 
Claudins are transmembrane proteins that seal tight junctions, bind with peripheral 
protein ZO-1 (zonula occludens-1), and are known to play an important role in several normal 
tissues and cancers. However, the role of claudin-1 and -7 expressions in esophageal 
squamous cell carcinoma remains to be clarified. In the present study, we confirmed the 
expressions of claudin-1, -7, and ZO-1 in the prickle cell layer of the normal human 
esophageal squamous epithelium. To clarify their role in the tumor progression, the 
expressions of claudin-1 and -7 at the invasive front of the esophageal squamous cell 
carcinoma were analyzed immunohistochemically. Reduced expression of claudin-7 at the 
invasive front of the esophageal cancer was significantly associated with the depth of invasion 
(P = 0.004), stage (P = 0.038), lymphatic vessel invasion (P = 0.001), and lymph node 
metastasis (P = 0.014). In contrast, significant association was not detected between claudin-1 
expression and clinicopathological factors, except histological differentiation of the tumor (P 
= 0.0029). Comparison of claudin-7 expression at the invasive front of the primary tumor and 
its corresponding metastatic lymph nodes revealed significant reduction in claudin-7 
expression in the metastatic lymph nodes (P = 0.007). These results suggest that the reduced 
expression of claudin-7 at the invasive front of esophageal squamous cell carcinoma may lead 
to tumor progression and subsequent metastatic events. Thus, claudin-7 can be a novel marker 
for the prediction of lymph node metastasis.  
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1. Introduction 
Cell-cell adhesion plays a critical role in the establishment and maintenance of cell 
polarity and cell society. It has long been known that cell-cell adhesiveness is generally 
reduced in various human cancers. Tumor cells are dissociated throughout the tumor masses, 
lose their cell polarity, and infiltrate the stroma, thereby leading to subsequent metastatic 
events in a scattered manner. The dissociation of cancer cells from cancer nests is a crucial 
step, and the suppression of cell-cell adhesiveness may trigger the release of cancer cells from 
the primary cancer nests and confer invasive properties on a tumor [1, 2]. Previous reports 
have indicated a relationship between carcinomas and tight junctions [3, 4].      
In simple epithelium, tight junctions are positioned at the boundary of the apical and 
basolateral plasma membranes, and play an important role in the paracellular barrier and cell 
polarity [5-8]. Several lines of evidence have revealed that the granular cell layer of stratified 
epithelium of the skin possesses tight junctions that are crucial for the barrier function [5, 6, 
9-11]. The tight junctions consist of membrane and peripheral proteins. Occludin and claudins 
are known as membrane proteins and ZO (zonula occludens) -1, -2, and -3 are peripheral 
proteins. Claudins are composed of 4 transmembrane domains and 2 extracellular loops 
through which they bind to corresponding claudins in the cell-cell contact. Claudins also bind 
to ZO-1, -2, or -3 via their carboxyl terminal in the cytoplasm [8, 9]. Claudin-1 and -7 are two 
members of the 24 claudin multigene family [8, 11]. The distribution of claudin-1 and -7 has 
been examined in several tissues, such as lung, breast, kidney, uterine cervical epithelium and 
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esophageal epithelium [8, 12-18]. Loss of claudin-7 expression has been observed in ductal 
carcinoma of the breast and in head and neck squamous cell carcinoma [15, 16]. In contrast, 
increased expression of both claudin-1 and -7 has been observed in squamous intraepithelial 
neoplasia and invasive carcinoma of the uterine cervix [17]. Enhanced expression of claudin-1 
has also been reported in colorectal cancer and esophageal squamous cell carcinoma [18, 19]. 
However, it remains to be clarified whether claudin-1 and -7 expressions in esophageal 
squamous cell carcinoma are associated with the malignant potential. 
In this study, we determined the expressions of claudin-1, -7, and ZO-1 in 17 cases of 
normal human esophageal squamous epithelium. To determine the significance of claudins in 
esophageal cancer, we also analyzed the correlation of claudin-1 and -7 expressions with the 
clinicopathological factors of esophageal squamous cell carcinoma.  
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2. Materials and methods 
2.1. Tissue samples 
For Western blot analysis, normal human esophageal tissues were obtained from 
autopsies undertaken within one or two hours after death at Kobe University Hospital from 
2004 to 2005, after obtaining written informed consent. Macroscopic and microscopic 
examinations revealed no significant postmortem changes in the esophageal tissues. The renal 
cortex was dissected from C57BL/6 mouse (Nippon SLC Co., Shizuoka, Japan) and used as 
positive control for both claudin-1 and -7 in western blotting [13, 14].  
A total of 62 squamous cell carcinomas of the esophagus were studied; these carcinomas 
were surgically resected at Kobe University Hospital from 1997 to 2004, without any 
presurgical chemotherapy or radiotherapy. Informed consent was obtained from all the 
patients. All the specimens were fixed in 10% formalin and embedded in paraffin. 
Histological typing and depth of invasion were determined according to the Guide Lines for 
the Clinical and Pathologic Studies on Carcinoma of the Esophagus proposed by the Japanese 
Society for Esophageal Diseases [20]. TNM classification was applied according to the 
guidelines of the International Union Against Cancer [21]. Selected blocks comprising 62 
primary carcinomas, 17 adjacent normal esophageal tissue samples, and 27 metastatic lymph 
nodes were sliced into 4-µm-thick sections for immunohistochemical analysis.   
 
2.2 Western blot analysis 
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Normal esophageal tissue and mouse renal cortex were lysed in a buffer containing 50 
mM Tris-HCl (pH 7.4), 125 mM NaCl, 0.1% Triton-X (Wako Pure Chemical Industries, Ltd., 
Osaka, Japan), 5 mM EDTA, 1% protease inhibitor, and 1% phosphatase inhibitor cocktail II 
(Sigma Chemical Co., Tokyo, Japan). Tissue lysates were separated by SDS-PAGE and then 
electrotransferred onto Immunobilon-P membrane (Millipore, Billerica, MA). Rabbit 
monoclonal antibodies (Abs) to claudin-1 (1:1000 dilution, Zymed Laboratories Inc., CA), 
rabbit polyclonal Abs to claudin-7 (1:1000 dilution, [22, 23]; Immuno-Biological Laboratories, 
Japan), rabbit polyclonal Abs for ZO-1 (1:1000 dilution, Zymed), and mouse monoclonal Abs 
to β-actin (1:1000 dilution, Sigma) were used for the primary reaction. The generation of 
primary rabbit polyclonal Abs against claudin-7 has been described elsewhere [22, 23]. 
Horseradish peroxidase-conjugated donkey anti-mouse IgG and sheep anti-rabbit IgG 
(Amersham Biosciences Corp., NJ) were used as secondary Abs. After washing with PBS 
containing 0.5% Tween-20, protein bands were visualized by enhanced chemiluminescence 
(ECL) method using Immunostar Reagent (Immunostar, Wako).  
 
2.3. Immunohistochemical analysis 
Immunohistochemical analysis was performed to evaluate the expression and distribution 
of claudin-1, -7, and ZO-1 in normal squamous epithelium samples and the expression of 
claudin-1 and -7 in esophageal squamous cell carcinomas. Rabbit monoclonal Abs to 
claudin-1 (1:100 dilution, Zymed), rabbit polyclonal Abs to claudin-7 (1:100 dilution [22, 23]; 
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Immuno-Biological Laboratories), and rabbit polyclonal Abs for ZO-1 (1:100 dilution, 
Zymed) were used for the primary reaction. Deparaffinized tissue sections were immersed in 
10 mM sodium citrate buffer (pH 6.0) and autoclaved for antigen retrieval. Endogenous 
peroxidase activity was blocked using methanol containing 0.03% H2O2. Following 
incubation with blocking buffer (0.01 M PBS containing 5% BSA [Sigma]), the sections were 
incubated with the primary Abs overnight at 4ºC. After gentle rinsing with 0.05 M Tris-HCl, 
the sections were incubated with biotinylated secondary Abs (LSAB2 kit, Dako Cytomation, 
CA, USA) for 30 min. Following this, the sections were again incubated with horseradish 
peroxidase conjugated streptavidin reagent (LSAB2 kit, Dako) for 30 min. Chromogenic 
fixation was performed for 5 min in a solution of 3-amino-9-ethyl carbazole substrate 
chromogen (Dako). The sections were counterstained with Meyer’s hematoxylin. 
   In normal esophageal epithelium samples, the expressions of claudin-1, -7, and ZO-1 were 
evaluated in each of the four layers of epithelium, namely, basal cell layer, prickle cell layer, 
lower surface layer, and upper surface layer. 
The degree of claudin-1 and claudin-7 expressions in carcinoma in situ, esophageal 
squamous cell carcinoma and metastatic lymph nodes were evaluated as follows: score 0, 
negative immunoreaction; score 1, spotted immunostaining on the cell membrane; score 2, 
strong linear immunoreactivity at cell-cell contact. Evaluation and scoring was performed at 
the area of the invasive front of each cancer tissue by two independent observers (YU and 
FN). 
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2.4. Statistical analysis 
The statistical correlations between the results of immunohistochemical analysis and 
clinicopathological factors were assessed by the χ2 –test. Staining intensities at the invasive 
front of the primary tumor and metastatic lymph nodes were compared using the Wilcoxon 
signed-ranks test. A P value less than 0.05 was considered as statistically significant. All 
statistical analyses were performed using the StatView software (SAS Institute Inc., NC). 
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3. Results 
3.1. Expressions of claudin-1, -7, and ZO-1 in normal human esophageal epithelium 
The immunohistochemical distribution of claudin-1, -7, and ZO-1 in 17 samples of 
normal human esophageal epithelium is summarized in Table 1. Claudin-1 and -7 were 
expressed at the cell-cell contact as a continuous linear pattern and had honeycomb-like 
appearance in the prickle cell layer (Fig.1A-D). Claudin-1 and -7 immunoreactivities were not 
detected in the basal cell layer. ZO-1 was expressed in the cytoplasm below the cell-cell 
contact of the prickle cell layer (Fig.1E, F). In contrast to the claudins, ZO-1 was expressed 
not only in the prickle cell layer but also in the basal cell layer in 3 samples. In 2 samples, 
ZO-1 was also expressed in the lower surface layer. Western blot analysis demonstrated that 
the Abs to claudin-1, -7, and ZO-1 detected specific single 22-kDa, 23-kDa, and 225-kDa 
bands, respectively, in the extracts of 4 normal esophageal tissue samples (Fig.1I).  
 
3.2. Expression of claudin-1 and -7 in carcinoma in situ and squamous cell carcinoma of 
the esophagus 
To investigate the expressions of claudin-1, and -7 in esophageal cancers, as well as their 
correlation with the clinicopathological factors, 60 squamous cell carcinomas and 2 cases of 
carcinoma in situ were evaluated by immunohistochemistry. In both cases of carcinoma in situ, 
no significant reduction in claudin-1 or -7 expressions was observed. In contrast to the limited 
expression in the prickle cell layer of the normal esophageal epithelium, both claudin-1 and -7 
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were expressed in the entire atypical cell layer of the carcinoma in situ (Fig.2A-C). In 
squamous cell carcinoma, claudin-1 and -7 immunoreactivities were observed at the cell-cell 
contact, but not in the cytoplasm or nucleus. Poorly differentiated squamous cell carcinomas 
demonstrated weak or loss of claudin-1 and -7 immunoreactivities (Fig.2D-F). On the other 
hand, well and moderately differentiated carcinomas showed strong immunoreactivities of 
both claudin-1 and -7 at the area of cornified differentiation (Fig.2G-I). Interestingly, the 
immunoreactivity of claudin-7 was heterogeneous in each cancer tissue of the esophageal 
cancer although the expression of claudin-1 was almost homogenous (Fig.3). Further, positive 
expression of claudin-7 in the upper portion of the cancerous lesion and obvious reduction or 
loss of claudin-7 expression at the invasive front was observed in 9 cases (Fig. 3C, F, G).  
 
3.3. Relationships between claudin-1 and -7 expressions at the invasive front and 
clinicopathological factors of esophageal squamous cell carcinomas 
The comparisons of claudin-1 and -7 expressions at the invasive front and 
clinicopathological factors in squamous cell carcinoma are summarized in Table 2. Reduction 
in claudin-1 and -7 expressions in esophageal squamous cell carcinoma were observed in 46 
(74%) cases and 44 (71%) cases, respectively. Reduction in claudin-7 expression at the 
invasive front was significantly associated with the depth of invasion (P = 0.004), stage (P = 
0.038), lymphatic vessel invasion (P = 0.001), and lymph node metastasis (P = 0.014). Poorly 
differentiated squamous cell carcinomas tended to lose claudin-7 expression in comparison 
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with other histological types (P = 0.076). Although the reduced expression of claudin-1 was 
significantly associated with histological differentiation of the tumor (P = 0.029), significant 
association was not detected between its expression and other clinicopathological factors.  
 
3.4. Comparison of claudin-1 and -7 expressions in the primary esophageal tumors and 
lymph node metastasis 
Of the 62 esophageal squamous cell carcinoma cases, 28 cases had lymph node 
metastasis. The immunoreactivities of claudin-1 and -7 in 27 available metastatic lymph 
nodes and at the invasive front of the corresponding primary tumors were compared. 
Reduction in claudin-1 and -7 expressions was observed in 7 and 10 cases, respectively. 
Despite the stable expression of claudin-1 at the both invasive fronts and in metastatic lymph 
nodes, reduced immunoreactivities of claudin-7 in the metastatic lymph nodes were observed 
in 6 cases (Fig.4A-F). When claudin-7 expression at the invasive front of the primary tumor 
and the corresponding metastatic lymph nodes was compared, a significant reduction in 
claudin-7 expression was observed in the metastatic lymph nodes (Fig.5B, P = 0.007). On the 
other hand, no significant reduction in claudin-1 expression was observed in metastatic lymph 
nodes when compared with that at the invasive front of the primary tumor (Fig.5A, P = 0.118). 
In 25 cases that showed reduced expression of claudin-7 at the invasive front of the cancerous 
lesion in comparison with that in normal epithelium, a further reduction in claudin-7 
immunoreactivity was observed in the corresponding metastatic lymph nodes in 6 cases.  
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4. Discussion 
In this study, we report the details of expression and distribution of claudin-1 and -7 in 
the normal esophageal stratified squamous epithelium. We detected claudin-1, -7, and ZO-1 
immunoreactivities in the prickle cell layer. In the stratified squamous epithelium of the skin, 
the expressions of claudin-1, -3, -4, -6, -7, -8, -11, -12, and -17 have been reported [5, 6, 9, 24, 
25]. Furuse et al. identified claudin-1 and -4 in the basal cell layer and granular cell layer in 
the skin of mouse; they reported that claudin-1-deficient mice died with wrinkled skin due to 
dehydration within 1 day of birth [6]. These findings indicate that tight junctions are crucial 
for the barrier function of the mammalian skin. The expressions of ZO-1, occludin, claudin-1, 
and claudin-7 have been shown in stratified squamous epithelium of the esophagus [3, 18, 26]. 
Our observations regarding ZO-1, claudin-1, and -7 expressions are in agreement with those 
of previous reports [3, 18].  
It is known that cell-cell adhesiveness is generally reduced in various human cancers. 
The dissociation of cancer cells from the primary cancer nests is a crucial step in metastasis, 
and the suppression of cell-cell adhesiveness may trigger the release of cancer cells from the 
primary cancer nests and confer invasive properties on a tumor [2]. In this study, we 
discovered significant reduction or loss of claudin-7 expression at the invasive front of 
esophageal squamous cell carcinoma. cDNA microarray comparison between matched normal 
epithelium and squamous cell carcinoma cells of the head and neck cancer demonstrated 
down-regulation of claudin-7 gene expression [16]. Inverse correlation between loss of 
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claudin-7 expression and nuclear grade in ductal carcinoma in situ or Elston grade in invasive 
ductal carcinoma of the breast has been reported [15]. The present study showed that the 
reduced expression of claudin-7 at the invasive front was statistically correlated with the 
depth of invasion, stage, lymphatic vessel invasion, and lymph node metastasis of esophageal 
cancer; this suggests that reduction or loss of claudin-7 expression may be correlated with 
tumor invasiveness and metastatic potential. 
The results obtained in our study are different from previous studies about claudin-1 and 
-7 expressions in cervical neoplasia [17] and esophageal squamous cell carcinoma [18]. 
Despite significant decrease in claudin-1 and -7 expressions in invasive carcinoma in 
comparison with intraepithelial neoplasm and carcinoma in situ of the uterine cervix, 
expressions of both claudins were still higher than those in the normal cervical epithelium, 
and no significant correlation was detected between T categories and claudin-7 expression 
[17]. Gyorffy et al. reported that the pattern and staining intensity of claudin-7 in esophageal 
squamous cell carcinoma did not change in comparison with those in normal squamous 
epithelium [18]. These discrepancies between our results and the others can be explained 
based on the tumor area selected for the evaluation of immunoreactivities. To investigate the 
relationship between claudin-1 and claudin-7 expressions and the malignant potential such as 
cancer cell proliferation, we observed the deepest invaded area called the invasive front [27]. 
On the other hand, Sobel et al. and Gyorffy et al. observed a randomly selected area [17, 18]. 
There was significant reduction of claudin-7 expression in metastatic lymph nodes when 
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compared with that at the invasive front of the corresponding primary tumors. Therefore, 
observations of claudin-7 expression at the invasive front may be important to evaluate its 
role in the esophageal cancer. 
Kominsky et al. found that hypermethylation of promoter sequences was the major 
mechanism involved in the silencing of claudin-7 expression in breast cancer cell lines [15]. 
Recent studies suggested the possibility of genetic and epigenetic changes in cell adhesion 
molecules in cancer cells [2]. Due to heterogeneous and reduced expression of claudin-7 at 
the invasive front and in metastatic lymph nodes, hypermethylation of claudin-7 might have 
occurred at the invasive front of the esophageal squamous cell carcinoma, where the reduction 
or loss of claudin-7 expression was detected.     
In conclusion, the present study provided evidence of reduction or loss of claudin-7 
expression at the invasive front and in metastatic lymph nodes; it also clarified the correlation 
of claudin-7 expression with tumor invasiveness and metastatic potential in esophageal 
squamous cell carcinoma. We consider that reduction or absence of claudin-7 expression can 
be a novel marker for the prediction of metastasis. Moreover, the elucidation of biological 
functions of claudin-7 at the invasive front of the tumor would be valuable in clarifying the 
mechanism of tumor invasiveness and metastasis.   
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Table legends 
Table 1 Distribution of claudin-1, -7, and ZO-1 immunoreactivities in normal esophageal 
squamous epithelium 
Expression and distribution of claudin-1, -7, and ZO-1 were evaluated in each of the four 
layers of epithelium; basal cell layer, prickle cell layer, lower surface layer and upper surface 
layer. M, male; F, female; U, including cervical esophagus and upper thoracic esophagus; M, 
middle thoracic esophagus; L, lower thoracic esophagus including abdominal esophagus; BL 
(+), expression in basal cell layer; PL (+), expression in prickle cell layer; LS (+), expression 
in lower surface layer. 
 
Table 2 Relationships between claudin-1 or -7 expression and clinicopathological factors of 
the esophageal squamous cell carcinomas 
a Expression of claudin-1 and -7 at the invasive front were scored as follows: score 0, negative 
expression; score 1, spotted staining in cell-cell contact; score 2, strong linear expression in 
cell-cell contact. 
b Statistical analysis was performed by the χ2 test with Yates’ correction. P values less than 
0.05 were considered to be statistically significant. 
c Locations were separated as follows: Upper, including cervical esophagus and upper thoracic 
esophagus; Middle, middle thoracic esophagus; Lower, lower thoracic esophagus including 
abdominal esophagus.  
 - 20 -
d According to the Guide Lines for the Clinical and Pathological Studies on Carcinoma of the 
Esophagus proposed by the Japanese Society for Esophageal Diseases [26]. CIS, carcinoma 
in situ; well, well differentiated squamous cell carcinoma; mod, moderately differentiated 
squamous cell carcinoma; poor, poorly differentiated squamous cell carcinoma.  
e According to the TNM classification by UICC [27]. 
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Figure legends 
Fig. 1 Immunohistochemistry using anti-claudin-1, anti-claudin-7 and anti-ZO-1 (zonula 
occludens-1) antibodies in serial sections of normal esophageal epithelium. (bar = 50 µm). I, 
Western blotting of claudin-1, -7, and ZO-1 in normal esophageal epithelium (Hm-Eso1-4). 
Mouse kidney tissues (Ms-kid) were used for positive control. 
 
Fig. 2 Immunohistochemistry of claudin-1 and -7 in esophageal squamous cell carcinoma. 
Carcinoma in situ shows strong expression of claudin-1 (B) and -7 (C) in atypical cell layer. 
Poorly differentiated squamous cell carcinoma shows reduced expression of claudin-1 (E) and 
-7 (F). Well differentiated squamous call carcinoma with cornified differentiation shows 
strong expressions of claudin-1 (H) and -7 (I). Original magnification, inset: ×400, bar = 100 
µm. 
 
Fig. 3 Immunohistochemical expressions of claudin-1 and -7 in a representative case of 
esophageal squamous cell carcinoma. In contrast to homogenous immunoreactivity of 
claudin-1 (B), claudin-7 (C) immunoreactivity is decreased as the progress of invasion. 
Higher magnification of upper potion of cancerous lesion away from invasive front (D and F) 
and invasive front (E and G) of claudin-1 and claudin-7 immunostaining are presented in 
lower panel. Original magnification, inset: ×400, bar = 100 µm). 
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Fig. 4 Claudin-1 and -7 expressions at the invasive front of the primary tumor and metastatic 
lymph node. Despite the stable expression of claudin-1 and -7 at the invasive front (B and C) 
reduced immunoreactivity of claudin-7 at the metastatic lymph node were observed (F); while 
the expression of claudin-1 did not changed (E). B and E: claudin-1, C and F: claudin-7, A-C: 
invasive front of the primary tumor, D-F: metastatic lymph node, original magnification, 
inset: ×400, bar = 100 µm. 
 
Fig. 5 Comparison of claudin-1 and -7 expressions at the invasive front of primary esophageal 
tumors and metastatic lymph nodes. No significant reduction of claudin-1 expression was 
observed in metastatic lymph nodes comparison with invasive front of the primary tumor (A, 
P = 0.118). Significant reduction of claudin-7 expression was observed in metastatic lymph 
nodes comparison with corresponding invasive front of the primary tumor (B, P = 0.007). 
Statistical analysis was performed by Wilcoxon signed-ranks test. P < 0.05 was considered to 
be statistically significant. ( : score 0, : score 1, : score 2) 
Table 1 Distribution of claudin-1, -7, and ZO-1 immunoreactivities in normal esophageal 
squamous epithelium 
Case Age/Gender Location claudin-1 claudin-7 ZO-1 
 1 69/M L  PL (+) PL (+) PL (+) 
 2 73/M M  PL (+) PL (+) BL (+), PL (+) 
 3 57/M M  PL (+) PL (+), LS (+) PL (+), LS (+) 
 4 60/F L  PL (+) PL (+), LS (+) PL (+), LS (+) 
 5 62/M U  PL (+) PL (+) PL (+) 
 6 77/M L  PL (+) PL (+) PL (+) 
 7 70/F L  PL (+) PL (+) PL (+) 
 8 69/M M  PL (+) PL (+) PL (+) 
 9 70/F L  PL (+) PL (+) PL (+) 
 10 78/M L  PL (+) PL (+) PL (+) 
 11 54/F M  PL (+) PL (+) PL (+) 
 12 59/M L  PL (+) PL (+) PL (+) 
 13 50/M L  PL (+) PL (+) PL (+) 
 14 50/M L  PL (+) PL (+) PL (+) 
 15 62/M U  PL (+) PL (+) BL (+), PL (+) 
 16 66/M M  PL (+) PL (+) BL (+), PL (+) 
 17 53/M L  PL (+) PL (+) PL (+) 
Table 2 Relationships between claudin-1 and -7 expression and clinicopathological factors of 
the esophageal squamous cell carcinomas 
 Score of claudin-1 expressiona   Score of claudin-7 expressiona 
  n 0 (%) 1 (%) 2 (%) P valueb   0 (%) 1 (%) 2 (%) P valueb 
Total  62 29 (47) 17 (27) 16 (26)  17 (27) 27 (44) 18 (29) 
Age 
  > 65 37 21 (56) 7 (20) 9 (24) 0.108 12 (32) 14 (38) 11 (30) 0.462
  65 ≥ 25 8 (32) 10 (40) 7 (28)  5 (20) 13 (52) 7 (28) 
Gender 
  Male 53 23 (43) 15 (28) 15 (28) 0.392 14 (26) 24 (45) 15 (29) 0.797 
  Female 9 6 (67) 2 (22) 1 (11)  3 (33) 3 (33) 3 (33)   
Locationc 
  Upper 13 5 (38) 4 (31) 4 (31) 0.468 5 (38) 5 (38) 3 (23) 0.835 
  Middle 31 17 (55) 9 (29) 5 (16)  7 (23) 15 (48) 9 (29) 
  Lower 18 7 (39) 4 (22) 7 (39)  5 (28) 7 (39) 6 (33) 
 
Histologyd       
  CIS 2 0 (0) 0 (0) 2 (100) 0.029 0 (0) 0 (0) 2 (100) 0.076 
 Well 12 6 (50) 3 (25) 3 (25)  3 (25) 3 (25) 6 (50) 
Mod 37 14 (38) 14 (38) 9 (24)  9 (24) 19 (51) 9 (24) 
Poor 11 9 (82) 0 (0) 2 (18)  5 (45) 5 (45) 1 (9) 
Depth of invasiond 
Tis 2 0 (0) 0 (0) 2 (100) 0.223 0 (0) 0 (0) 2 (100) 0.004 
T1        20 10 (50) 6 (30) 4 (20)  4 (20) 6 (30) 10 (50) 
T2        12 4 (33) 3 (25) 5 (42)     1 (8) 9 (75) 2 (17) 
T3        26 13 (50) 8 (31) 5 (19)   10 (38)  12 (46)  4 (15) 
T4         2 2 (100) 0 (0) 0 (0)    2 (100)  0 (0)  0 (0)  
Stagee 
0-IIa 26 13 (50) 7 (27) 6 (23) 0.890 3 (12) 10 (38)  13 (50) 0.038 
IIb-IVb 36  16 (44) 10 (28) 10 (28)     14 (38)  17 (47) 5 (13) 
Vessel invasion 
Lymphatic vessels 
Negative 15 6 (40) 3 (20) 6 (40) 0.344 5 (33) 1 (6) 9 (60) 0.001 
Positive 47 23 (49) 14 (30) 10 (21)  12 (25) 26 (55) 9 (19) 
Venous vessels 
Negative 24 12 (50) 5 (21) 7 (29) 0.645  5 (20)  8 (33)  11 (45) 0.068 
Positive 38  17 (45) 12 (32) 9 (23)  12 (31)  19 (50)  7 (18) 
Lymph node metastasis 
Negative 34 16 (47) 9 (26) 9 (26) 0.981 8 (23)  11 (32) 15 (44) 0.014 
Positive 28 13 (46) 8 (29) 7 (25)  9 (32) 16 (57) 3 (10) 





